pubmed-article:20513072 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20513072 | lifeskim:mentions | umls-concept:C0220847 | lld:lifeskim |
pubmed-article:20513072 | lifeskim:mentions | umls-concept:C0019682 | lld:lifeskim |
pubmed-article:20513072 | lifeskim:mentions | umls-concept:C0205653 | lld:lifeskim |
pubmed-article:20513072 | lifeskim:mentions | umls-concept:C0021747 | lld:lifeskim |
pubmed-article:20513072 | lifeskim:mentions | umls-concept:C0035525 | lld:lifeskim |
pubmed-article:20513072 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
pubmed-article:20513072 | lifeskim:mentions | umls-concept:C0439661 | lld:lifeskim |
pubmed-article:20513072 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:20513072 | pubmed:dateCreated | 2010-5-31 | lld:pubmed |
pubmed-article:20513072 | pubmed:abstractText | Limited evidence is available currently regarding the efficacy and safety of pegylated interferon (PEG-IFN) and ribavirin in patients co-infected perinatally with human immunodeficiency virus (HIV) and hepatitis C virus (HCV). No information is available on whether or not these patients should be treated earlier for infection with HCV. This report describes four patients with HIV and HCV co-infection acquired perinatally, who were treated with PEG-IFN and ribavirin for chronic viral hepatitis caused by HCV. | lld:pubmed |
pubmed-article:20513072 | pubmed:language | eng | lld:pubmed |
pubmed-article:20513072 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20513072 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20513072 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20513072 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20513072 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20513072 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20513072 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20513072 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20513072 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20513072 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20513072 | pubmed:month | Jul | lld:pubmed |
pubmed-article:20513072 | pubmed:issn | 1096-9071 | lld:pubmed |
pubmed-article:20513072 | pubmed:author | pubmed-author:ViscoliClaudi... | lld:pubmed |
pubmed-article:20513072 | pubmed:author | pubmed-author:BernardiniCla... | lld:pubmed |
pubmed-article:20513072 | pubmed:author | pubmed-author:Di... | lld:pubmed |
pubmed-article:20513072 | pubmed:author | pubmed-author:RossoRaffaell... | lld:pubmed |
pubmed-article:20513072 | pubmed:author | pubmed-author:MikulskaMalgo... | lld:pubmed |
pubmed-article:20513072 | pubmed:author | pubmed-author:NiccoElenaE | lld:pubmed |
pubmed-article:20513072 | pubmed:copyrightInfo | (c) 2010 Wiley-Liss, Inc. | lld:pubmed |
pubmed-article:20513072 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20513072 | pubmed:volume | 82 | lld:pubmed |
pubmed-article:20513072 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20513072 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20513072 | pubmed:pagination | 1110-4 | lld:pubmed |
pubmed-article:20513072 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:meshHeading | pubmed-meshheading:20513072... | lld:pubmed |
pubmed-article:20513072 | pubmed:year | 2010 | lld:pubmed |
pubmed-article:20513072 | pubmed:articleTitle | Safety and efficacy of pegylated interferon and ribavirin in adolescents with human immunodeficiency virus and hepatitis C virus acquired perinatally. | lld:pubmed |
pubmed-article:20513072 | pubmed:affiliation | Infectious Diseases Clinic, University of Genoa, San Martino Hospital, Genoa, Italy. | lld:pubmed |
pubmed-article:20513072 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20513072 | pubmed:publicationType | Case Reports | lld:pubmed |